Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2025-12-26 @ 3:32 AM
Study NCT ID:
NCT04501120
Status:
RECRUITING
Last Update Posted:
2025-09-26
First Post:
2020-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Sponsor:
Ascentage Pharma Group Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2028-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-03
First Submit QC Date:
None
Study First Post Date:
2020-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-23
Last Update Post Date:
2025-09-26
Last Update Post Date Type:
ESTIMATED